Involuted TLS as a harbinger of HCC regression

Xin Liu; Dan G. Duda

doi:10.1038/s41590-024-01990-y

Involuted TLS as a harbinger of HCC regression

Xin Liu, Dan G. Duda

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

Tertiary lymphoid structures (TLS) have different stages and cellular compositions in human tumors. New data are showing the effect of neoadjuvant immunotherapy on the fate of TLS in treatment-responsive versus treatment-resistant liver cancers.

Original language	English (US)
Pages (from-to)	1986-1987
Number of pages	2
Journal	Nature immunology
Volume	25
Issue number	11
DOIs	https://doi.org/10.1038/s41590-024-01990-y
State	Published - Nov 2024

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1038/s41590-024-01990-y

Cite this

@article{87c9fd3788d7410d9b5b0ad4bbb8476b,

title = "Involuted TLS as a harbinger of HCC regression",

abstract = "Tertiary lymphoid structures (TLS) have different stages and cellular compositions in human tumors. New data are showing the effect of neoadjuvant immunotherapy on the fate of TLS in treatment-responsive versus treatment-resistant liver cancers.",

author = "Xin Liu and Duda, \{Dan G.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature America, Inc. 2024.",

year = "2024",

month = nov,

doi = "10.1038/s41590-024-01990-y",

language = "English (US)",

volume = "25",

pages = "1986--1987",

journal = "Nature immunology",

issn = "1529-2908",

publisher = "Nature Research",

number = "11",

}

TY - JOUR

T1 - Involuted TLS as a harbinger of HCC regression

AU - Liu, Xin

AU - Duda, Dan G.

N1 - Publisher Copyright: © Springer Nature America, Inc. 2024.

PY - 2024/11

Y1 - 2024/11

N2 - Tertiary lymphoid structures (TLS) have different stages and cellular compositions in human tumors. New data are showing the effect of neoadjuvant immunotherapy on the fate of TLS in treatment-responsive versus treatment-resistant liver cancers.

AB - Tertiary lymphoid structures (TLS) have different stages and cellular compositions in human tumors. New data are showing the effect of neoadjuvant immunotherapy on the fate of TLS in treatment-responsive versus treatment-resistant liver cancers.

UR - https://www.scopus.com/pages/publications/85207469845

UR - https://www.scopus.com/inward/citedby.url?scp=85207469845&partnerID=8YFLogxK

U2 - 10.1038/s41590-024-01990-y

DO - 10.1038/s41590-024-01990-y

M3 - Comment/debate

C2 - 39455892

AN - SCOPUS:85207469845

SN - 1529-2908

VL - 25

SP - 1986

EP - 1987

JO - Nature immunology

JF - Nature immunology

IS - 11

ER -

Involuted TLS as a harbinger of HCC regression

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this